Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | UBE2D2 |
Upstream (Parents) |
---|
(<<) CYB561D1 → UBE2D2 |
(<<) CYB5R3 → UBE2D2 |
(<<) EXOC3L2 → UBE2D2 |
(<<) FLJ35390 → UBE2D2 |
(<<) FOXO3 → UBE2D2 |
(<<) IL23A → UBE2D2 |
(<<) KLK3 → UBE2D2 |
(<<) MAP3K10 → UBE2D2 |
(<<) MAP3K2 → UBE2D2 |
(<<) MSN → UBE2D2 |
(<<) PDIA3 → UBE2D2 |
(<<) PLD3 → UBE2D2 |
(<<) PNO1 → UBE2D2 |
(<<) RPL35A → UBE2D2 |
(<<) SHC1 → UBE2D2 |
(<<) STK11 → UBE2D2 |
(<<) THOC4 → UBE2D2 |
(<<) UBE2I → UBE2D2 |
Downstream (Children) |
---|
UBE2D2 → CDR2 (>>) |
UBE2D2 → CNIH4 (>>) |
UBE2D2 → CTRB2 (>>) |
UBE2D2 → FDPS (>>) |
UBE2D2 → HDAC3 (>>) |
UBE2D2 → HDAC4 (>>) |
UBE2D2 → HSPA4 (>>) |
UBE2D2 → HSPA5 (>>) |
UBE2D2 → ITGA6 (>>) |
UBE2D2 → MIA3 (>>) |
UBE2D2 → MTMR6 (>>) |
UBE2D2 → NFATC4 (>>) |
UBE2D2 → PAK1 (>>) |
UBE2D2 → PPP3CB (>>) |
UBE2D2 → PRNP (>>) |
UBE2D2 → PRSS3 (>>) |
UBE2D2 → RAB15 (>>) |
UBE2D2 → RAB22A (>>) |
UBE2D2 → RBKS (>>) |
UBE2D2 → RPL26L1 (>>) |
UBE2D2 → RRP15 (>>) |
UBE2D2 → TCEAL1 (>>) |
UBE2D2 → TRIM32 (>>) |
UBE2D2 → UST (>>) |